Welcome back to another insightful blog post where we dive deep into the world of stocks that I currently own. In today’s post, we’ll be analyzing and discussing the latest events shaping the market on September 4, 2023. So, sit tight and let’s get started!
I'm Nathan Hawkins and I am passionate about the stock market. I love to research and analyze US stocks and identify the best ones to invest in.
Good day readers! In today’s blog post, I will be discussing the latest news in the stock market about the companies I own. We will be covering Nano Dimension, ACELYRIN, Aurora Mobile, 17 Education & Technology Group, and NIO Inc. So, let’s dive into the details and see how the companies have performed during the…
Welcome back to our daily blog post about stocks! Today, we have some exciting news to share about the recent financial results and announcements of some of the companies we own stocks in. So, let’s dive right in and see how our investments are performing Kura Sushi USA, Inc. Announces Strong Q3 Results and Growth…
Welcome back to another daily blog post where I share updates on the stocks in my investment portfolio. Today, we’ll be discussing the financial results of Crown Crafts, FactSet, Methode Electronics, Avid Bioservices, and La-Z-Boy for the fourth quarter and full year of fiscal 2023. Let’s dive in and examine how these companies have performed…
Introduction: Mercury Systems Inc. Releases Fourth Quarter and Full Fiscal Year 2023 Financial Results Mercury Systems Inc. (NASDAQ: MRCY) recently announced the release of its fourth-quarter and full fiscal year 2023 financial results, providing valuable insights into the company’s performance in the aerospace and defense sectors. As a technology company, Mercury Systems delivers cutting-edge processing…
Introduction: LPL Financial Holdings Inc. Announces Second Quarter Financial Results LPL Financial Holdings Inc. (Nasdaq: LPLA), the parent corporation of LPL Financial LLC, has revealed that it will report its second quarter financial results after the market closes on July 27. The company will also be hosting a conference call at 5 p.m. ET on…
Introduction: OKYO Pharma Limited Announces Positive Developments with Flagship Drug OK-101 to Treat Dry Eye Disease OKYO Pharma Limited (NASDAQ: OKYO), a leading ophthalmology-focused bio-pharmaceutical company, has reported financial results for the twelve months ended March 31, 2023, along with an update on its lead program, OK-101. The company’s CEO, Gary Jacob, expressed his satisfaction…
